Aperio Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.47M | Sell |
2,615
-408
| -13% | -$229K | ﹤0.01% | 1385 |
|
|
2020
Q3 | $2.11M | Buy |
3,023
+688
| +29% | +$481K | 0.01% | 1092 |
|
|
2020
Q2 | $1.85M | Buy |
2,335
+714
| +44% | +$564K | 0.01% | 1150 |
|
|
2020
Q1 | $965K | Buy |
1,621
+327
| +25% | +$195K | ﹤0.01% | 1326 |
|
|
2019
Q4 | $1.47M | Buy |
1,294
+356
| +38% | +$404K | 0.01% | 1237 |
|
|
2019
Q3 | $1.12M | Sell |
938
-23
| -2% | -$27.4K | ﹤0.01% | 1338 |
|
|
2019
Q2 | $1.58M | Buy |
961
+41
| +4% | +$67.5K | 0.01% | 1177 |
|
|
2019
Q1 | $1.88M | Buy |
920
+173
| +23% | +$353K | 0.01% | 1060 |
|
|
2018
Q4 | $960K | Buy |
747
+239
| +47% | +$307K | ﹤0.01% | 1333 |
|
|
2018
Q3 | $960K | Sell |
508
-55
| -10% | -$104K | ﹤0.01% | 1428 |
|
|
2018
Q2 | $1.15M | Buy |
563
+50
| +10% | +$102K | 0.01% | 1298 |
|
|
2018
Q1 | $1.14M | Buy |
513
+12
| +2% | +$26.6K | 0.01% | 1245 |
|
|
2017
Q4 | $1.16M | Buy |
501
+92
| +22% | +$212K | 0.01% | 1223 |
|
|
2017
Q3 | $728K | Buy |
409
+23
| +6% | +$40.9K | ﹤0.01% | 1462 |
|
|
2017
Q2 | $525K | Buy |
386
+38
| +11% | +$51.7K | ﹤0.01% | 1631 |
|
|
2017
Q1 | $410K | Buy |
348
+48
| +16% | +$56.6K | ﹤0.01% | 1670 |
|
|
2016
Q4 | $239K | Buy |
300
+24
| +9% | +$19.1K | ﹤0.01% | 1903 |
|
|
2016
Q3 | $243K | Buy |
+276
| New | +$243K | ﹤0.01% | 1833 |
|
|
2015
Q4 | – | Sell |
-351
| Closed | -$389K | – | 1990 |
|
|
2015
Q3 | $389K | Buy |
351
+140
| +66% | +$155K | ﹤0.01% | 1437 |
|
|
2015
Q2 | $461K | Buy |
211
+34
| +19% | +$74.3K | ﹤0.01% | 1371 |
|
|
2015
Q1 | $276K | Buy |
+177
| New | +$276K | ﹤0.01% | 1625 |
|